Jun‐Long Liang

1.5k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Jun‐Long Liang is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Jun‐Long Liang has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Biomedical Engineering, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Jun‐Long Liang's work include Nanoplatforms for cancer theranostics (20 papers), Cancer Research and Treatments (7 papers) and Immune cells in cancer (6 papers). Jun‐Long Liang is often cited by papers focused on Nanoplatforms for cancer theranostics (20 papers), Cancer Research and Treatments (7 papers) and Immune cells in cancer (6 papers). Jun‐Long Liang collaborates with scholars based in China, New Zealand and Iran. Jun‐Long Liang's co-authors include Xian‐Zheng Zhang, Xiao‐Kang Jin, Qian‐Xiao Huang, Wei‐Hai Chen, Guo‐Feng Luo, Shi‐Man Zhang, Mei‐Ting Niu, Chuan‐Jun Liu, Bing Wang and Junmin Wan and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Jun‐Long Liang

31 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma

2023 123 citations Qian‐Xiao Huang, Jun‐Long Liang et al. Nano Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun‐Long Liang China	19	711	330	290	289	278	31	1.2k
Yongkang Yu China	16	484 0.7×	277 0.8×	142 0.5×	224 0.8×	187 0.7×	34	924
Kishwor Poudel South Korea	22	681 1.0×	345 1.0×	210 0.7×	263 0.9×	445 1.6×	32	1.1k
Sunny Kumar India	12	383 0.5×	492 1.5×	159 0.5×	135 0.5×	478 1.7×	36	1.2k
Zhijun Ouyang China	21	577 0.8×	433 1.3×	140 0.5×	227 0.8×	376 1.4×	42	1.1k
Suxin Li China	15	435 0.6×	619 1.9×	534 1.8×	115 0.4×	284 1.0×	42	1.4k
Ji‐Gang Piao China	20	989 1.4×	515 1.6×	90 0.3×	378 1.3×	568 2.0×	49	1.6k
Xiao‐Kang Jin China	16	520 0.7×	258 0.8×	218 0.8×	234 0.8×	178 0.6×	32	847
Hanqing Qian China	25	725 1.0×	689 2.1×	220 0.8×	249 0.9×	752 2.7×	58	1.8k
Weifen Zhang China	19	277 0.4×	403 1.2×	152 0.5×	192 0.7×	192 0.7×	41	1.1k
Dengshuai Wei China	20	786 1.1×	561 1.7×	144 0.5×	416 1.4×	408 1.5×	29	1.4k

Countries citing papers authored by Jun‐Long Liang

Since Specialization

Citations

This map shows the geographic impact of Jun‐Long Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Long Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Long Liang more than expected).

Fields of papers citing papers by Jun‐Long Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Long Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Long Liang. The network helps show where Jun‐Long Liang may publish in the future.

Co-authorship network of co-authors of Jun‐Long Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Long Liang. A scholar is included among the top collaborators of Jun‐Long Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Long Liang. Jun‐Long Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wei‐Hai, Ziyi Han, Shi‐Man Zhang, et al.. (2025). Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids. Cell Metabolism. 37(6). 1277–1293.e8. 5 indexed citations

Meng, Ran, Shi‐Man Zhang, Hong Chen, et al.. (2025). Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy. Nano Letters. 25(9). 3670–3680. 2 indexed citations

Liang, Jun‐Long, Xiao‐Kang Jin, Qian‐Xiao Huang, et al.. (2024). Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy. Materials Today. 78. 251–296. 14 indexed citations

Wang, Jia‐Wei, Ping Ji, Jin‐Yue Zeng, et al.. (2024). Engineered bacterium-metal-organic framework biohybrids for boosting radiotherapy with multiple effects. Biomaterials. 314. 122901–122901. 9 indexed citations

Liang, Jun‐Long, et al.. (2024). Amplifying Ca2+ overload by engineered biomaterials for synergistic cancer therapy. Biomaterials. 316. 123027–123027. 12 indexed citations

Liang, Jun‐Long, Shi‐Man Zhang, Ran Meng, et al.. (2024). Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy. Advanced Materials. 36(36). e2405673–e2405673. 25 indexed citations

Ji, Ping, Xiao‐Kang Jin, Shi‐Man Zhang, et al.. (2024). Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy. Nano Letters. 24(15). 4691–4701. 6 indexed citations

Liang, Jun‐Long, Xiao‐Kang Jin, Shi‐Man Zhang, et al.. (2023). Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Science Bulletin. 68(6). 622–636. 96 indexed citations

Huang, Qian‐Xiao, Jun‐Long Liang, Ke Li, et al.. (2023). Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota. Biomaterials. 301. 122274–122274. 67 indexed citations

10.

Liu, Xinhua, Jia‐Xin An, Jun‐Long Liang, et al.. (2023). Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy. ACS Nano. 17(24). 24947–24960. 24 indexed citations

11.

Huang, Qian‐Xiao, Jun‐Long Liang, Qi‐Wen Chen, et al.. (2023). Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 51. 101911–101911. 123 indexed citations breakdown →

12.

Liang, Jun‐Long, Xiao‐Kang Jin, Guo‐Feng Luo, et al.. (2023). Immunostimulant Hydrogel-Guided Tumor Microenvironment Reprogramming to Efficiently Potentiate Macrophage-Mediated Cellular Phagocytosis for Systemic Cancer Immunotherapy. ACS Nano. 17(17). 17217–17232. 47 indexed citations

13.

Zhang, Qiuling, Sheng Hong, Xue Dong, et al.. (2022). Bioinspired nano-vaccine construction by antigen pre-degradation for boosting cancer personalized immunotherapy. Biomaterials. 287. 121628–121628. 18 indexed citations

14.

Liang, Jun‐Long, Mei‐Ting Niu, Guo‐Feng Luo, et al.. (2022). Tailor-made biotuner against colorectal tumor microenvironment to transfer harms into treasures for synergistic oncotherapy. Nano Today. 47. 101662–101662. 12 indexed citations

15.

Luo, Guo‐Feng, Jun‐Long Liang, Diwei Zheng, et al.. (2022). Inhibiting Stress‐Activated Signals to Reverse Heat Resistance for Augmented Photothermal Therapy Based on Biologically Derived Nanotherapeutics. Advanced Functional Materials. 32(36). 14 indexed citations

16.

Liang, Jun‐Long, Guo‐Feng Luo, Wei‐Hai Chen, & Xian‐Zheng Zhang. (2021). Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy. Advanced Materials. 33(31). e2007630–e2007630. 165 indexed citations

17.

Liang, Jun‐Long, Xiao‐Kang Jin, Biling Chen, et al.. (2020). Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy. Nanotechnology. 31(19). 195103–195103. 21 indexed citations

18.

Liang, Jun‐Long, Qianwei Huang, Jinhua Hu, et al.. (2019). pH‐Responsive Nanoparticles Loaded with Graphene Quantum Dots and Doxorubicin for Intracellular Imaging, Drug Delivery and Efficient Cancer Therapy. ChemistrySelect. 4(20). 6004–6012. 23 indexed citations

19.

Wang, Bing, Xiaopeng Su, Jun‐Long Liang, et al.. (2018). Synthesis of polymer-functionalized nanoscale graphene oxide with different surface charge and its cellular uptake, biosafety and immune responses in Raw264.7 macrophages. Materials Science and Engineering C. 90. 514–522. 60 indexed citations

20.

Zhu, Wenjing, Lin Liu, Qian Liao, et al.. (2016). Functionalization of cellulose with hyperbranched polyethylenimine for selective dye adsorption and separation. Cellulose. 23(6). 3785–3797. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact